PFE Stock - Pfizer Inc.

PFE Stock Chart

PFE Profile

Pfizer Inc. is a global company that discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. It offers a wide range of medicines and vaccines in various therapeutic areas. These include cardiovascular, metabolic, and women's health products under the Premarin family and Eliquis brands; cancer treatments under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, as well as oral COVID-19 treatments under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands.

Pfizer also provides vaccines and medicines for diseases such as pneumoccoccal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under brands like Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family. The company produces biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands. Additionally, it offers treatments for amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. Pfizer is also involved in contract manufacturing and serves a diverse group of clients, including wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices.

Founded in 1849 and headquartered in New York, New York, Pfizer has established numerous collaboration agreements with companies such as Bristol-Myers Squibb, Astellas Pharma US, Myovant Sciences, Akcea Therapeutics, Merck KGaA, Valneva SE, BioNTech SE, and Arvinas. This allows Pfizer to expand its reach and impact in the biopharmaceutical industry.

PFE Revenue Chart

PFE Earnings

Analyst Ratings